202 related articles for article (PubMed ID: 25069302)
1. [The functions and clinical studies of macrophage migration inhibitory factor].
Zhao R; Yao WJ
Sheng Li Ke Xue Jin Zhan; 2014 Apr; 45(2):93-9. PubMed ID: 25069302
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
Hertelendy J; Reumuth G; Simons D; Stoppe C; Kim BS; Stromps JP; Fuchs PC; Bernhagen J; Pallua N; Grieb G
Curr Med Chem; 2018 Feb; 25(5):601-605. PubMed ID: 28714387
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
[TBL] [Abstract][Full Text] [Related]
4. MIF in autoimmunity and novel therapeutic approaches.
Stosic-Grujicic S; Stojanovic I; Nicoletti F
Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
6. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y
J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992
[TBL] [Abstract][Full Text] [Related]
7. MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.
Tilstam PV; Qi D; Leng L; Young L; Bucala R
Expert Opin Ther Targets; 2017 Jul; 21(7):671-683. PubMed ID: 28562118
[TBL] [Abstract][Full Text] [Related]
8. Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.
Djudjaj S; Martin IV; Buhl EM; Nothofer NJ; Leng L; Piecychna M; Floege J; Bernhagen J; Bucala R; Boor P
J Am Soc Nephrol; 2017 Dec; 28(12):3590-3604. PubMed ID: 28801314
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived MIF: a novel platelet chemokine with distinct recruitment properties.
Wirtz TH; Tillmann S; Strüßmann T; Kraemer S; Heemskerk JW; Grottke O; Gawaz M; von Hundelshausen P; Bernhagen J
Atherosclerosis; 2015 Mar; 239(1):1-10. PubMed ID: 25561410
[TBL] [Abstract][Full Text] [Related]
10. Platelets are a previously unrecognised source of MIF.
Strüßmann T; Tillmann S; Wirtz T; Bucala R; von Hundelshausen P; Bernhagen J
Thromb Haemost; 2013 Nov; 110(5):1004-13. PubMed ID: 23846621
[TBL] [Abstract][Full Text] [Related]
11. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.
Thiele M; Donnelly SC; Mitchell RA
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180072
[TBL] [Abstract][Full Text] [Related]
12. Studying the Pro-Migratory Effects of MIF.
Hoffmann A; Zwißler LC; El Bounkari O; Bernhagen J
Methods Mol Biol; 2020; 2080():1-18. PubMed ID: 31745866
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
[TBL] [Abstract][Full Text] [Related]
14. Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
Shen D; Lang Y; Chu F; Wu X; Wang Y; Zheng X; Zhang HL; Zhu J; Liu K
Expert Opin Ther Targets; 2018 Jul; 22(7):567-577. PubMed ID: 29856236
[TBL] [Abstract][Full Text] [Related]
15. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity.
Flaster H; Bernhagen J; Calandra T; Bucala R
Mol Endocrinol; 2007 Jun; 21(6):1267-80. PubMed ID: 17389748
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.
Lerch JK; Puga DA; Bloom O; Popovich PG
Semin Immunol; 2014 Oct; 26(5):409-14. PubMed ID: 24768088
[TBL] [Abstract][Full Text] [Related]
17. Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Pasqualon T; Lue H; Groening S; Pruessmeyer J; Jahr H; Denecke B; Bernhagen J; Ludwig A
Biochim Biophys Acta; 2016 Apr; 1863(4):717-26. PubMed ID: 26852939
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
19. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
